Key result
Persistent RV impairment early after TMVr is linked to ~125% higher death and HF hospitalization risk.
Why the study?
The change in right-ventricular function after transcatheter mitral valve repair is still poorly understood.
Does the early response of right-ventricular function to transcatheter mitral valve repair predict mortality and heart failure hospitalization in patients with mitral regurgitation?
Cohort (n=816)
Yes
Does the early response of right-ventricular function to transcatheter mitral valve repair predict mortality and heart failure hospitalization in patients with mitral regurgitation?
Early changes in right ventricular function after transcatheter mitral valve repair are strongly predictive of 2-year mortality and heart failure hospitalization.
Answers are grounded in this paper and cite their sources.
May aid post-TMVR prognostication via early RV assessment; extends observational data but leaves causal impact open.
BACKGROUND: The change in right-ventricular function (RVF) after transcatheter mitral valve repair is still poorly understood. We assessed the early response of RVF to the MitraClip procedure and its clinical relevance. METHODS: We analyzed consecutive patients who underwent a MitraClip procedure to treat MR between August 2010 and March 2019 in the Heart Failure Network Rhineland registry. RVF was assessed before and after the procedure. Impaired RVF was defined as an RV fractional area change (RVFAC) < 35% or tricuspid annular plane systolic excursion (TAPSE) < 16 mm. RESULTS: 816 eligible patients (77 ± 9 years, 58.5% male) were included in the analysis. Baseline values of RVF were: RVFAC 38.6 (IQR 29.7-46.7) % and TAPSE 17.0 (IQR 14.0-21.0) mm. At a median time of 3 (IQR 2-5) days after the procedure, the RVF remained normal in 34% (n = 274), normalized in 17% (n = 140), deteriorated in 15% (n = 125), and was persistently impaired in 34% (n = 277) of patients. The RVF response was significantly associated with a composite outcome of all-cause mortality and hospitalization due to heart failure within a 2-year follow-up. Compared to stable/normal RVF, the adjusted hazard ratios for the outcome were 1.78 (95% CI 1.10-2.86) for normalized RVF, 1.89 (95% CI 1.34-3.15) for deteriorated RVF, and 2.25 (95% CI 1.47-3.44) for persistently impaired RVF. Changes in TAPSE and RVFAC as continuous variables were significantly correlated with the outcome. CONCLUSION: An early change in RVF following transcatheter mitral valve repair is predictive of mortality and hospitalization due to heart failure during follow-up. Early response of RVF after MitraClip and its clinical significance. An acute, early change in RVF can be observed following the MitraClip procedure, which is associated with the risk of mortality and hospitalization for HF.
No takes yet. Share an insight, caveat, or question.
Sugiura et al. (2021) conducted a cohort in Mitral regurgitation (n=816). Persistently impaired right-ventricular function vs. Stable/normal right-ventricular function was evaluated on Composite of all-cause mortality and hospitalization due to heart failure within 2 years (HR 2.25, 95% CI 1.47-3.44, p=<0.001). Persistently impaired right-ventricular function early after transcatheter mitral valve repair was associated with an increased risk of mortality and heart failure hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: